The esophagogastric junctional adenocarcinoma an increasing disease
- PMID: 28740657
- PMCID: PMC5506153
- DOI: 10.21037/jtd.2017.05.70
The esophagogastric junctional adenocarcinoma an increasing disease
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988-2012: A Single-institution, High-volume Experience in China.Ann Surg. 2016 Jan;263(1):88-95. doi: 10.1097/SLA.0000000000001148. Ann Surg. 2016. PMID: 25647058 Free PMC article.
References
-
- Liu K, Zang W, Chen X, et al. Comparison on Clinicopathological Features and Prognosis Between Esophagogastric Junctional Adenocarcinoma (Siewert II/III Types) and Distal Gastric Adenocarcinoma: Retrospective Cohort Study, a Single Institution, High Volume Experience in China. Medicine (Baltimore) 2015;94:e1386. 10.1097/MD.0000000000001386 - DOI - PMC - PubMed
-
- Messager M, de Steur WO, van Sandick JW, et al. Variations among 5 european countries for curative treatment of resectable oesophageal and gastric cancer: A survey from EURECCA Upper GI Group (Europian Registration of Cancer CAre). Eur J Surg Oncol 2016;42:116-22. 10.1016/j.ejso.2015.09.017 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources